Home/CytoAgents/Dr. Johannes Wolff
DJ

Dr. Johannes Wolff

Chief Medical Officer

CytoAgents

CytoAgents Pipeline

DrugIndicationPhase
CTO1681CAR T-Cell/TCE Therapy-Related Inflammation (CRS/ICANS)Phase 1b/2a